Tyco and ALARIS settle patent litigation:
This article was originally published in Clinica
Executive Summary
Tyco Healthcare Group has granted ALARIS Medical a paid-up licence to certain patents in a deal that also settles a patent litigation lawsuit between the two companies. The litigation related to disposable probe covers for use with ALARIS' infrared tympanic thermometers. Financial details were not disclosed. ALARIS, which also makes the IMED and IVAC intravenous infusion therapy systems and the Istromedix cardiac event recorders and pacemaker follow-up systems, will not have to pay any future royalties on patents covered by the agreement. San Diego, California-based ALARIS says a portion of the settlement will be treated as a prepaid licence with the remainder being taken in the third-quarter against previously established reserves.
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.